Back to Search
BARBARA JESSEN, M.D.
M.D.
Neurology Physician
NPI: 1255595062Individual
Specialties, Licenses & Credentials
Neurology PhysicianPrimary
Psychiatry & Neurology — Neurology
Code: 2084N0400X
MD00026104(WA)
Research & Publications (20)
Evaluation of the cytotoxic effects of ophthalmic solutions containing benzalkonium chloride on corneal epithelium using an organotypic 3-D model.
PMID 19638217·BMC Ophthalmol·2009
7-preclinical
Clinical significance of p53 alterations in surgically treated prostate cancers.
PMID 18552821·Mod Pathol·2008
8-other
Toxicity and toxicokinetics of the cyclin-dependent kinase inhibitor AG-024322 in cynomolgus monkeys following intravenous infusion.
PMID 18509643·Cancer Chemother Pharmacol·2008
7-preclinical
Pharmacologic properties of AG-012986, a pan-cyclin-dependent kinase inhibitor with antitumor efficacy.
PMID 18413795·Mol Cancer Ther·2008
7-preclinical
Effect of the multitargeted tyrosine kinase inhibitors imatinib, dasatinib, sunitinib, and sorafenib on mitochondrial function in isolated rat heart mitochondria and H9c2 cells.
PMID 18664550·Toxicol Sci·2008
7-preclinical
Antisense inhibition of 11betahydroxysteroid dehydrogenase type 1 improves diabetes in a novel cortisone-induced diabetic KK mouse model.
PMID 18029262·Biochem Biophys Res Commun·2008
7-preclinical
Influence of a single viral epitope on T cell response and disease after infection of mice with respiratory syncytial virus.
PMID 18056370·J Immunol·2007
7-preclinical
Inhibiting matrix metalloproteinases with prinomastat produces abnormalities in fetal growth and development in rats.
PMID 16607633·Birth Defects Res B Dev Reprod Toxicol·2006
7-preclinical
Retinal and peripheral nerve toxicity induced by the administration of a pan-cyclin dependent kinase (cdk) inhibitor in mice.
PMID 16698721·Toxicol Pathol·2006
7-preclinical
Gastric and pancreatic lesions in rats treated with a pan-CDK inhibitor.
PMID 16392173·Toxicol Pathol·2005
7-preclinical
Increase in thyroid follicular cell tumors in nelfinavir-treated rats observed in a 2-year carcinogenicity study is consistent with a rat-specific mechanism of thyroid neoplasia.
PMID 16408618·Hum Exp Toxicol·2005
7-preclinical
A distal region of the human TGM1 promoter is required for expression in transgenic mice and cultured keratinocytes.
PMID 15061870·BMC Dermatol·2004
7-preclinical
Assessment of hepatocytes and liver slices as in vitro test systems to predict in vivo gene expression.
PMID 12832660·Toxicol Sci·2003
4-observational
Expression profiling during adipocyte differentiation of 3T3-L1 fibroblasts.
PMID 12459256·Gene·2002
7-preclinical
Pulmonary gas exchange and acid-base state at 5,260 m in high-altitude Bolivians and acclimatized lowlanders.
PMID 11896002·J Appl Physiol (1985)·2002
4-observational
Qualitative and quantitative risk assessment for human salmonellosis due to multi-resistant Salmonella Typhimurium DT104 from consumption of Danish dry-cured pork sausages.
PMID 11849720·Prev Vet Med·2002
7-preclinical
Keratinocyte differentiation marker suppression by arsenic: mediation by AP1 response elements and antagonism by tetradecanoylphorbol acetate.
PMID 11485391·Toxicol Appl Pharmacol·2001
4-observational
Functional AP1 and CRE response elements in the human keratinocyte transglutaminase promoter mediating Whn suppression.
PMID 10974538·Gene·2000
7-preclinical
Role of Sp1 response element in transcription of the human transglutaminase 1 gene.
PMID 10886517·J Invest Dermatol·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1847 SW SHOREVIEW LN
BURIEN, WA 98146 - Phone
- (206) 242-0201
Quick Facts
- NPI
- 1255595062
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile